16 May 2014 14:56
Electrical Geodesics, Inc.
Notice of Annual General Meeting
EUGENE, OREGON, US, 16 May 2014 - Electrical Geodesics, Inc. ("EGI" or the "Company"), a leading neurodiagnostic medical technology company, today posted its Notice of Annual General Meeting ("AGM") to shareholders.
The AGM will be held on June 16, 2014 at 9:30 a.m., pacific daylight time at the Company's offices located at 500 East 4th Avenue, Suite 200, Eugene, OR 97401, USA. The Notice of the AGM and the Proxy Information Statement can be found at the Company's website www.egi.com.
EGI | |
UK: Christine Soden, CFO | +44 (0) 7710 484199 |
Peel Hunt LLP (NOMAD and Broker) | +44 (0) 20 7418 8900 |
James Steel, Clare Terlouw | |
FTI Consulting (PR Advisors) | +44 (0) 20 3727 1000 |
Simon Conway, Mo Noonan |
About EGI
Founded in 1992, EGI designs, develops and commercialises a range of non-invasive neurodiagnostic products used to monitor and interpret brain activity based on its proprietary dense array electroencephalography ("dEEG") platform technology. The Company's technology uses up to 256 sensors, providing much higher resolution brain activity data compared to conventional 8 or 16 channel EEG and is used in medical, clinical and research settings in a diverse range of applications including important areas such as the diagnosis and monitoring of epilepsy, neurosurgical planning, sleep assessment, and many others.
EGI's dEEG systems, available in the GES 300 and now the GES 400 lines, capitalize on the Company's unique Hydrocel Geodesic Sensor Net which allows faster, easier, and more convenient placement of many EEG sensors in an even distribution over the entire scalp, providing more accurate and precise diagnosis and measurement. EGI's technology is now widely used in neuroscience research laboratories and is becoming more commonly used in clinics, care centers, and hospitals around the world. Data is measured and visualised using EGI's proprietary amplifier technology and software, providing a complete, advanced, high-resolution EEG platform. The Company's products are compatible with multiple diagnostic and imaging technologies, including magnetic resonance (MR) imaging, functional MRI (fMRI), and magneto-encephalography (MEG).
In April 2013 EGI commenced trading on the London Stock Exchange AIM market under the symbol EGI.L. Seewww.egi.comfor more information on the Company.